ESR1 and breast cancer: On the contrary, overexpression of ESR1 in breast cancer cells reversed the beneficial effects of SSD on cell apoptosis, as cell apoptosis was significantly reduced upon ESR1 overexpression (p < 0.01; Fig. 6E and F).